Medicare BALANCE Obesity Drug Pilot Collapses
Medicare's BALANCE obesity drug pilot has failed after insurers declined to join, forcing the government to seek alternative GLP-1 coverage paths.
The latest public health coverage from Hawaii Medical Journal.
Medicare's BALANCE obesity drug pilot has failed after insurers declined to join, forcing the government to seek alternative GLP-1 coverage paths.
A 237-trial meta-analysis identifies which vaccine uptake intervention components workâand why effectiveness varies by age, population, and pandemic context.
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.
The White House is circulating draft drug pricing legislation to major pharma companies, escalating Trump's push to reshape U.S. medication pricing policy.
The suspension of GP Helen Eisenhauser highlights how primary care systems fail to support physician-parents, especially women managing childcare demands.
The FTC reached a proposed settlement with CVS Caremark over allegations its PBM artificially inflated insulin prices and blocked patient access.
A 24-state coalition sues the EPA over its rescission of the 2009 endangerment finding, with major public health and climate regulation implications.
A federal judge reversed HHS vaccine policy changes by RFK Jr., restoring the childhood vaccine schedule and creating a crossroads for the Trump administration.
CMS is evaluating automatic enrollment of Medicare beneficiaries into Medicare Advantage plans or ACOs, a major policy shift under the Trump administration.